Onderneming Capricor Therapeutics, Inc.
Aandelen
CAPR
US14070B3096
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,41 USD | +5,05% | +7,98% | +10,63% |
Vakgebied
Aantal werknemers: 102
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Transformative Cell and Exosome-based Therapeutics
100,0
%
| 3 | 100,0 % | 25 | 100,0 % | +886,81% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 25 | 100,0 % | +886,81% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 60 | 20-11-13 |
Anthony Bergmann
DFI | Director of Finance/CFO | 38 | 20-11-13 |
Kristi Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Karen Krasney
LAW | General Counsel | 71 | 01-01-12 |
General Counsel | 71 | 28-02-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Philip Gotwals
BRD | Director/Board Member | 61 | 21-07-23 |
Earl Collier
BRD | Director/Board Member | 76 | 20-11-13 |
George Dunbar
BRD | Director/Board Member | 77 | 20-11-13 |
David Musket
BRD | Director/Board Member | 66 | 20-11-13 |
Frank Litvack
CHM | Chairman | 68 | 01-01-12 |
Karimah Es Sabar
BRD | Director/Board Member | 66 | 23-07-21 |
Linda Marbán
CEO | Chief Executive Officer | 60 | 20-11-13 |
Paul Auwaerter
BRD | Director/Board Member | 62 | 13-07-23 |
Michael Kelliher
BRD | Director/Board Member | 47 | 01-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 31 502 972 | 28 874 629 ( 91,66 %) | 0 | 91,66 % |
Bedrijfsgegevens
Capricor Therapeutics, Inc.
10865 Road to the Cure Suite 150
92121, San Diego
+858 727 1755
http://www.capricor.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,63% | 170 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers CAPR
- Onderneming Capricor Therapeutics, Inc.